Article
Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts.
Kidney international - 1 Oct 2026
Lebraud Emilie, Aubert Olivier, Aouni Laïla, Garcia Virginia, Morin Lise, Eloudzeri Maëva, Lamarthée Baptiste, Zuber Julien, Ramaugé Parra Corentin, Try Mélanie, Coemans Maarten, Kuypers Dirk, Wellekens Karolien, Debyser Tim, Lehnert Priyanka Koshy, Abderrahmane Adel, Taupin Jean-Luc, Jager Chloé, Holleville Quentin, Normand Corinne, Bienaimé Frank, Garcelon Nicolas, Terzi Fabiola, Naesens Maarten, Rabant Marion, Anglicheau Dany
Abstract excerpt
INTRODUCTION: Antibody-mediated rejection (AMR) remains a leading cause of kidney allograft failure, with both HLA and non-HLA antibodies implicated in its pathogenesis. The contribution of non-HLA antibodies (non-HLA Abs) to microvascular inflammation (MVI) and graft outcome, particularly in cases lacking donor-specific anti-HLA antibodies (HLA-DSAs), remains incompletely understood. METHODS: We analyzed 571...
Read the complete abstract on PubMedTopics
- Humans
- Kidney Transplantation
- Graft Rejection
- Female
